首页»供应»医药、保养 » 原料药»CAS 14636-12-5

CAS 14636-12-5

  • 面议
  • 起订量:0
  • 可售数量:0
  • 发布时间:2021-03-24产品供应时间:长期有效




联系人:沈 (先生)
  • 浙江凯发工贸有限公司
  • [免费会员1年] 信用度:0级
  • 会员级别:普通会员 第1年 信用度:0级
  • 店铺等级:
  • 联系人:沈(先生) 
  • 已缴纳 0.00 元保证金
  • 在线联系:
  • 会员状态:[当前离线] [加为商友] [发送信件]
  • 企业类型:企业单位
  • 经营模式:贸易商,服务商
  • 经营范围:原料药与中间体
  • 产品详情
  • 联系方式
  • 产品评价
  • 品牌:
  • 所属分类:医药、保养 » 原料药
  • 计量单位:
  • 最小起订量:0
  • 供货总量:0
  • 发货期限:自买家付款之日起3天内发货

 Product Name: Terlipressin Acetate

Synonyms: 36T125; D06672; Q324147; DB02638; HS-2028; CS-5769; EX-A3116; HY-12554; SC-47098; J-008213; Variquel; Remestyp; LS-161411; GTPL11241; CCG-270662; 14636-12-5; Glypressin; CHEBI:135905; Tox21_113374; SCHEMBL22699; TERLIPRESSIN; CHEMBL2135460; DTXSID7048952; Lucassin (TN); AKOS015994637; Terlipressina; Terlipressine; Glycylpressin; C52H74N16O15S2; CAS-14636-12-5; TerlipressinuM; NCGC00185754-01; EINECS 238-680-8; DSSTox_CID_28878; DSSTox_RID_83146; DSSTox_GSID_48952; Thymosin α1 Acetate; Thymosin al Acetate; Terlipressin Acetate; Terlipressin [BAN:INN]; Terlipressin (USAN/INN); Terlipressine [INN-French]; Terlipressinum [INN-Latin]; Terlipressina [INN-Spanish]; Terlipressin [USAN:INN:BAN]; Terlipressin Diacetate Salt; Terlipressin acetate, >=98%; Triglycyl-8-lysine-vasopressin; 1-Triglycyl-8-lysine Vasopressin; 130: PN: WO2010033207 SEQID: 171 claiMed protein; N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin; H-Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2; Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2 (disulfide bridge 4:9)
CAS Registry number: 14636-12-5
Molecular Formula: C52H74N16O15S2
Boiling Point: 1824 °C at 760 mmHg
Flash Point: 1056.9 °C
Refractive index: 1.664
Density: 1.46 
Appearance: White powder

Pharmacological effects: Terlipressin is a novel long-acting synthetic vasopressin reagent,its chemical name is three glycyl lysine vasopressin, it is a prodrug, itself has no activity ,in vivo  , it removes three glycyl residues in its N-terminus by aminopeptidase, and slowly "releases" the active lysine vasopressin. It is this "slow release" mechanism that makes it maintain the smooth muscle contraction up to 10 hours after a single administration, whereas the same dose of vasopressin, it can maintain its activity for 20-40 minutes. On the other hand,because of the slow digestion,  lysine vasopressin in the circulation cannot reach toxic levels, and usage of  terlipressin is safer.

Pharmacological effect of terlipressin is splanchnic vascular smooth muscle contraction, and reduction of visceral blood flow (such as reducing blood flow in the mesentery, spleen, uterus, etc.), thereby reducing portal vein blood flow,and reducing portal pressure, on the other hand it may also reduce plasma renin concentration, thereby increasing the renal blood flow in patients with hepatorenal syndrome, to improve kidney function, and increase urine output. Terlipressin is currently the only drug which is able to increase mortality in patients with esophageal varices bleeding , it is previously mainly used in clinical for the treatment of variceal bleeding, in addition,terlipressin now has also been successfully used for liver and kidney integrated syndrome and refractory shock, it is also likely to play a useful role in the cardiopulmonary resuscitation . Compared with vasopressin, it has a lasting effect, and it does not cause dangerous complications, including promoting  fibrinolysis and severe complications in the cardiovascular systems, and the use of it is simple (available intravenous injection), it is more suitable for rescue and treatment of emergent and critical  patients.

Uses: N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin is an analogue of vasopressin used as a vasoactive drug in the management of hypotension. N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin is used norepinephrine-resistant septic shock and hepatorenal syndrome. N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin is also used in the treatment of acute variceal bleeding.

关键词:CAS 14636-12-5,供应,医药、保养,原料药

  • 产品详情
  • 联系方式
  • 产品评价
立即询价 面议